Clinical Research
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2006; 12(39): 6331-6338
Published online Oct 21, 2006. doi: 10.3748/wjg.v12.i39.6331
Figure 3
Figure 3 Actuarial survival curves for distal spleno-renal shunt (DSRS) and endoscopic sclerotherapy (ES). DSRS vs ES for the first 5 years (breslow test P = 0.038) while no differences were found in the final outcome (log rank test P = 0.1168)